A new SAP evaluation is generally required when a relapse results in a new DOT drug or alcohol violation, including a positive return-to-duty or follow-up test. If substance use occurs while you are still completing the original treatment plan, your current Substance Abuse Professional may instead need to reassess your progress and revise recommendations. The key questions are whether a new violation occurred and where you are in the return-to-duty process.
A previous completion report does not clear a later violation. At the same time, a clinical relapse does not automatically mean every part of your original process must restart unchanged.
The key distinction: relapse versus a new DOT violation
Relapse is a clinical issue; a DOT violation is a regulatory determination. They can overlap, but they are not interchangeable.
A verified positive DOT drug test, a confirmed DOT alcohol result of 0.04 or higher or a refusal to take a required DOT test can trigger the federal SAP process. Under 49 CFR § 40.285, an employee who violates applicable DOT drug and alcohol rules cannot perform DOT safety-sensitive duties again until completing the required evaluation, referral and education or treatment process.
Other situations require closer review. For example, a positive test collected by a treatment program is not automatically a DOT test. Self-reported use can still have regulatory consequences under the rules governing your transportation industry.
Your employer’s designated employer representative, often called the DER, handles the employer’s DOT testing responsibilities. Your SAP assesses clinical needs and compliance. Neither role should be replaced by assumptions about what a relapse “probably” means.
When a new SAP evaluation is required
Use the following situations to identify the likely next step. Your employer and evaluator still need to review the actual records.
| Situation | What it generally means | Next step |
|---|---|---|
| A return-to-duty test is verified positive, or a required test is refused | A new DOT violation has occurred | Remain out of safety-sensitive work and complete another required SAP process |
| A DOT follow-up, random or other required test establishes a new violation after returning | Previous clearance does not cover the new violation | Immediate removal from safety-sensitive duties and another return-to-duty process |
| Substance use occurs during the original education or treatment plan | Clinical progress and recommendations need reassessment | Notify the current SAP; determine whether there is also a separate DOT violation |
| Use is disclosed without a DOT test | Agency rules and the circumstances of the admission matter | Obtain employer and SAP guidance before assuming either exemption or automatic restart |
| A court, probation office or non-DOT employer requests reassessment | A separate requirement may apply | Confirm which authority requires the report and what it must address |
A new violation requires new compliance steps, not necessarily a different evaluator or an identical treatment plan.
Relapse before the original process is complete
If you have not yet received the SAP’s follow-up determination of successful compliance, report the relapse to your current evaluator and treatment provider. They need accurate information about what happened, when it happened and what support you need now.
Your SAP evaluation findings and recommendations may need updating. Depending on the clinical assessment, that could involve more treatment, a different level of care or additional evidence of progress before a successful-compliance report can be issued. Relapse does not automatically establish that residential treatment is necessary.
If the event also constitutes a new DOT violation, the employer and SAP must address that violation rather than treating it only as a setback in counseling.
The SAP follow-up evaluation assesses your response to the recommended education or treatment. It is different from the employer’s return-to-duty test and from the follow-up testing that occurs after you resume safety-sensitive work.
A positive return-to-duty test after SAP clearance
Completing treatment and receiving a successful-compliance report does not, by itself, authorize a return to safety-sensitive duties. The employer must also satisfy the return-to-duty testing requirements.
Under 49 CFR § 40.305, the required return-to-duty test must have a negative drug result and/or an alcohol result below 0.02, as applicable. The employer, not the SAP, decides whether to return you to work after the regulatory conditions are met.
If that test establishes a new violation, another SAP evaluation is required. An earlier completion report cannot substitute for addressing the new result. You also cannot resolve a verified positive simply by arranging another test yourself and submitting a negative result.
Ask the DER to confirm the official test status and coordinate the next referral. That helps prevent paying for an assessment that does not address the correct violation.
A new violation after you have returned to work
Once you are back in a safety-sensitive position, a new DOT violation requires removal from those duties and another compliant return-to-duty process. This applies even if you completed the earlier recommendations, passed your original return-to-duty test and have been working successfully for months.
The new SAP evaluation should consider the current event alongside your treatment history and response to the earlier plan. Previous participation is relevant clinical information, but it does not excuse the new violation.
A new process also requires follow-up testing as directed by the SAP. Under 49 CFR § 40.307, a follow-up plan includes at least six unannounced tests during the first 12 months of safety-sensitive duty and may extend for up to 60 months. Do not assume that tests completed under an earlier plan satisfy the requirements following a new violation.
Changing employers does not erase the violation or eliminate outstanding DOT requirements. Federal eligibility to return also does not guarantee that an employer will retain or rehire you.
Does voluntarily reporting a relapse change the requirement?
Voluntary disclosure is clinically useful, but it is not a universal exemption from DOT rules. In some circumstances, an admission can establish prohibited use even without a positive DOT test.
FMCSA has a limited provision for voluntary self-identification under a qualifying written employer policy. 49 CFR § 382.121 sets conditions for that exception, including that the admission cannot be made to avoid a required test. It also requires appropriate evaluation, assistance and conditions for returning to safety-sensitive functions.
Whether a new SAP evaluation is mandatory therefore depends on more than whether you volunteered the information. The applicable agency rules, timing and employer policy matter.
Be truthful with your provider and employer. Do not assume that self-reporting guarantees an exemption, or that avoiding disclosure prevents a violation from being established. If you may be impaired, do not perform safety-sensitive work.
Do you have to use a different SAP?
Needing another assessment does not automatically mean needing another provider. Your existing SAP may be able to evaluate the new event, with access to your earlier recommendations and treatment history.
However, a new SAP evaluation cannot be used to shop for an easier recommendation. 49 CFR § 40.295 prohibits seeking a second SAP opinion after an initial evaluation for the same violation. A genuine new violation is different from disagreeing with the original treatment recommendation.
If your evaluator is unavailable, has closed the practice or cannot continue your case, ask how the records and case should be handled before booking elsewhere. Explain whether you need continued management of an existing case or assessment after a new violation.
Also confirm that the professional meets DOT’s SAP qualification requirements. A general substance use assessment, court evaluation or treatment discharge summary does not automatically replace the DOT process.
What to do before booking another appointment
Start by identifying the event that needs to be addressed. “I relapsed” provides important clinical information, but the evaluator also needs to know whether there was a DOT test, a refusal determination, an admission or a separate employer action.
Before scheduling a new SAP evaluation, gather the records that establish your current status:
- Testing and violation records: The official result or refusal documentation, including the date and test type.
- Previous SAP reports: The original recommendations and any follow-up determination already issued.
- Treatment documentation: Attendance records, completion information and updates from your treatment provider.
- Employer information: The DER’s contact details and written instructions concerning your removal or referral.
If you do not have a document, ask the DER or provider how it can be shared appropriately. Do not delay contacting your treatment team while trying to assemble a perfect file.
During scheduling, explain whether you were still in treatment, awaiting a return-to-duty test or already back at work when the event occurred. Ask which appointment type is appropriate and what records must arrive beforehand.
Finally, separate appointment availability from clearance. A fast appointment or promptly delivered report cannot remove required treatment, testing or employer review. There is no universal number of days after relapse that makes someone eligible to return.
Frequently asked questions
Does one relapse mean I must repeat exactly the same treatment? No. A new violation requires the applicable DOT process, but recommendations must reflect the SAP’s assessment. Your history, current substance use and response to previous care can affect the plan. Do not assume the duration or level of care will be identical.
Is a positive treatment-program test the same as failing a DOT test? No. A clinical test is not automatically a DOT test. It can still affect treatment recommendations and the SAP’s assessment of compliance. The circumstances may also reveal a violation under applicable agency rules, so the result should not be ignored.
Can I work while waiting for another SAP evaluation? You cannot perform DOT safety-sensitive duties after a disqualifying violation until the required return-to-duty conditions are met. Whether non-safety-sensitive work is available depends on the employer and any other applicable restrictions.
Does my previous completion report expire when I relapse? The central issue is not a universal expiration date. An earlier report documents the earlier process; it does not clear a later violation. If relapse occurs before you return, contact the SAP because the previous compliance determination may need reassessment.
Can an online appointment handle a relapse-related case? A remote appointment may be appropriate when it meets applicable DOT requirements. Confirm the provider’s qualifications, the assessment format and whether the appointment addresses your new violation or continues your existing case.
Arrange the right assessment for your situation
Affordable Evaluations offers nationwide telehealth services for DOT SAP and return-to-duty cases, with secure video appointments and licensed, certified evaluators.
When contacting the team about its DOT SAP return-to-duty program, explain when the relapse occurred, whether a new DOT violation was established and which steps you already completed. Those details help identify the appropriate next appointment without confusing a new case with an unfinished earlier process.
